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Abstract
Background. A study conducted as part of the development of the Eleventh International
Classification of Mental Disorders for Primary Health Care (ICD-11 PHC) provided an oppor-
tunity to test the relationships among depressive, anxious and somatic symptoms in PHC.
Method. Primary care physicians participating in the ICD-11 PHC field studies in five coun-
tries selected patients who presented with somatic symptoms not explained by known physical
pathology by applying a 29-item screening on somatic complaints that were under study for
bodily stress disorder. Patients were interviewed using the Clinical Interview Schedule-Revised
and assessed using two five-item scales that measure depressive and anxious symptoms.
Structural models of anxious-depressive symptoms and somatic complaints were tested
using a bi-factor approach.
Results. A total of 797 patients completed the study procedures. Two bi-factor models fit the
data well: Model 1 had all symptoms loaded on a general factor, along with one of three spe-
cific depression, anxiety and somatic factors [x2 (627) = 741.016, p < 0.0011, RMSEA = 0.015,
CFI = 0.911, TLI = 0.9]. Model 2 had a general factor and two specific anxious depression and
somatic factors [x2 (627) = 663.065, p = 0.1543, RMSEA = 0.008, CFI = 0.954, TLI = 0.948].
Conclusions. These data along with those of previous studies suggest that depressive, anxious
and somatic symptoms are largely different presentations of a common latent phenomenon.
This study provides support for the ICD-11 PHC conceptualization of mood disturbance, espe-
cially anxious depression, as central among patients who present multiple somatic symptoms.
Introduction
Primary health care (PHC) patients who are psychologically distressed often present with a
combination of depressive, anxious and somatic symptoms (Lieb et al., 2007; Löwe et al.,
2008; Hanel et al., 2009). However, the predominant classifications of mental disorders, the
International Classification of Diseases (ICD-10) (World Health Organization, 1992) and
the Diagnostic and Statistical Manual of Mental Disorders (DSM 5) (American Psychiatric
Association, 2013), do not provide a way to integrate these aspects of clinical presentations.
To improve the assessment of common mental health disorders by PHC professionals, future
classification systems need to provide categories that better correspond to clinical presentations
in PHC settings.
The World Health Organization (WHO), as part of the revision of the ICD-10, is cur-
rently preparing the Eleventh International Classification of Mental Disorders for Primary
Health Care (ICD-11 PHC) (Goldberg et al., 2016). Two of the newly proposed diagnoses,
anxious depression (AD) and bodily stress syndrome (BSS), have been tested through field
trials in PHC settings of five large countries (Goldberg et al., 2016, 2017a, 2017b). The inclu-
sion of a single diagnosis of AD was supported by many studies that showed the high
co-occurrence of depression and anxiety in PHC (Üstün and Sartorius, 1995; Kessler
et al., 2005). A screening instrument has been developed for the identification of depression
and anxiety based on two short 5-item scales suitable for administration by primary care
physicians (PCPs) in settings where administration of written questionnaires may not be
feasible (Goldberg et al., 2012, 2017b).
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Additionally, current diagnostic constructs for somatoform
disorder, somatization disorder and medically unexplained symp-
toms have generated controversy regarding their clinical utility
and validity. Arguments against these constructs include the fol-
lowing: (a) a lack of construct and predictive validity; (b) poor dis-
criminant validity due to high comorbidity with mood and
anxiety disorders and their overlap with functional somatic syn-
dromes (irritable bowel syndrome, chronic fatigue syndrome
and fibromyalgia); (c) particularly in the case of medically unex-
plained symptoms, the fact that the construct is based on the
exclusion of medical etiologies rather than on positive biopsycho-
social features; and (d) these constructs do not facilitate a positive
therapeutic dialogue between clinicians and patients because they
are unhelpful in describing symptoms and their causes and imply
that patients exaggerate or imagine their symptoms (Kroenke,
2007; Kroenke et al., 2007; Tófoli et al., 2011).
BSS is a disorder proposed for the ICD-11 PHC to replace the
‘Medically Unexplained Symptoms’ diagnosis in the previous ver-
sion of the classifications for PHC (ICD-10 PHC) (Lam et al.,
2013). The change is based in part on studies carried out by
Fink et al. (2007), who examined the latent structure of somatic
symptoms not explained by known physical pathology. BSS pro-
vides a single overall category for different ‘functional’ and soma-
toform disorders that could be exacerbated by stress rather than
being distinct diseases of non-cerebral pathology. For the
ICD-11 PHC, the BSS defines the presentation of three or more
somatic symptoms that are associated with distress and/or inter-
ference with daily functioning and are not explained by a
known physical pathology (Goldberg et al., 2016).
Using a standardized psychiatric interview, the field trials of
the ICD-11 PHC showed that 80.1% of patients who met the def-
inition of BSS had depressive or anxious comorbidity, most com-
monly AD (Goldberg et al., 2016). These results and the observed
overlap between depressive and anxious symptoms observed in a
subsequent study (Goldberg et al., 2017b) raise questions about
the extent to which BSS, depression, and anxiety represent distinct
phenomena in primary care patients. Only one study has analyzed
structural models to explain the relationship between somatoform
and emotional disorders in PHC patients (Simms et al., 2012).
This study found that a hierarchical bi-factor model was the
best fit for the data. Depressive, anxiety and somatic symptoms
were all loaded onto a general factor, along with three specific
depressive, anxiety and somatic factors. This suggested the pres-
ence of a broad internalizing factor linking diverse emotional dis-
orders and somatic complaints.
The purpose of this study was to investigate whether the
depressive, anxiety and somatic symptoms proposed for BSS
and AD in the ICD-11 PHC could be used in PHC as reliable
indicators of these disorders. With this aim, we tested the fit
and reliability of dimensional models of ICD-11 PHC depressive,
anxious and somatic symptoms presented by participants of the
ICD-11 PHC field studies.
Methodology
Data were collected as part of field studies for the ICD-11 PHC
conducted between October 2013 and July 2015 in Brazil (São
Paulo and Rio de Janeiro), the People’s Republic of China
(Hong Kong), Mexico (Jalisco), Pakistan (Rawalpindi) and
Spain (Oviedo). This cross-sectional study consisted of three
parts: (1) an evaluation of proposed brief scales for the identifica-
tion of depression, anxiety, and AD in primary care (Goldberg
et al., 2017b); (2) an evaluation of the proposed ICD-11 PHC
categories of BSS and health anxiety and the relationship between
these phenomena and depressive and anxiety disorders (Goldberg
et al., 2016); and (3) an evaluation of PCPs’ views and implemen-
tation of the proposed changes in these two areas for ICD-11
PHC (Lam et al., 2013; Goldberg et al., 2017a). Data included
in the present analyses were collected during the second part of
the study.
All procedures used in these studies were approved by the
WHO Research Ethics Review Committee and the appropriate
local institutional review bodies in every participating country.
Participants
PCPs were instructed by local investigators to refer adult patients
(older than 18 years) seen in a routine PHC practice for partici-
pation in the study. The inclusion criterion for part 2 was the
presence of at least three somatic symptoms not accounted for
by a known physical pathology, as rated by the PCP on a checklist
that included 29 somatic symptoms under study for the proposed
ICD-11 PHC diagnosis of BSS. PCPs could write in additional
symptoms not listed, which also counted toward the minimum
of three. (See section on Measures, below.)
Patients who agreed to participate were referred to a trained
Research Assistant who, after explaining the procedures and
obtaining informed consent, administered a computer-guided
interview consisting of the Clinical Interview Schedule-Revised
(CIS-R) (Lewis et al., 1992), the 12-item WHO Disability
Assessment Schedule 2.0 (WHODAS 2.0) (World Health
Organization, 2010), and the 5-item anxiety and depression scales
(Goldberg et al., 2017b) containing the symptoms proposed for
depression and anxiety for the ICD-11 PHC.
The procedures for part 2 of the study and sample character-
istics have been described in more detail elsewhere (Goldberg
et al., 2016).
Measures
We analyzed the latent structure and reliability of the item-level
symptom data related to depression, anxiety and somatic symp-
toms using the two 5-item depression and anxiety scales adminis-
tered by the Research Assistants and the 29 somatic symptom
items rated by the PCPs.
5-item depression and anxiety scales
Depression and anxiety were assessed using two 5-item scales ori-
ginally developed based on a study of PHC patients in 14 coun-
tries (Goldberg et al., 2012). These scales were applied and
validated against a structured diagnostic interview (Goldberg
et al., 2017b). The scales address depressive and anxiety symp-
toms that have been suggested for the assessment of the new
AD category of the ICD-11 PHC (Lam et al., 2013). Each scale
includes two screening questions, with three additional questions
to be asked if the reply to either of these is positive. (More details
regarding the two 5-item scales can be found in Goldberg et al.,
2017b).
Somatic symptoms screening
The somatic symptoms screening test contains a list of 29 somatic
symptoms including those proposed by Fink et al. (2007) for the
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assessment of BSS. There are nine gastrointestinal symptoms,
seven cardiorespiratory symptoms, eight musculoskeletal symp-
toms and five symptoms described as ‘general symptoms’ (head-
ache, dizziness, memory impairment, concentration difficulties
and fatigue). The PCPs indicated whether these symptoms were
present and whether there was a medical explanation for the
symptoms.
CIS revised
ICD-11 PHC diagnostic criteria were generated based on the
CIS-R applied by research assistants. The Programmable
Questionnaire System (PROQSY) CIS-R is a computerized ver-
sion of the CIS (Lewis et al., 1992), a fully structured interview
designed to be used by lay interviewers to assess ICD-10 diagno-
ses. For this study, the algorithms were adapted to generate
ICD-11 PHC diagnoses of AD, current anxiety, depressive epi-
sode and sub-threshold anxious depression (when significant
symptoms of both anxiety and depression are present, but the
diagnostic requirements for depression or current anxiety separ-
ately are not met) and no diagnosis.
12-Item WHO disability assessment schedule 2.0
This is a brief version of the 36-item scale developed by the WHO
to rate disability levels experienced over the past 30 days due to
health conditions. The 12-item scores were summed to generate
a total score between 0 (no disability) and 48 (maximum
disability).
Data analysis
In total, 797 patients presenting with somatic symptoms not
explained by known physical pathology completed the study pro-
cedures. To examine the latent structure of depressive, anxiety and
somatic symptoms presented by primary care patients, we used
the Mplus software package, Version 7.4 (Muthén and Muthén,
1998–2015), to perform confirmatory factor analyses (CFA).
CFA are used to provide construct validity of psychological scales
by correlating a set of continuous latent measures underlying sets
of observed variables (i.e. items or symptoms in a questionnaire)
(Brown, 2015). Under the CFA approach, different models might
be specified and tested regarding their reliability and fit. In a
bi-factor model, a general factor reflects the target construct
assessed by all the symptoms and the orthogonal (i.e. not corre-
lated) group-specific factors (depression, anxiety and somatiza-
tion in this case) represent subdomain constructs based on
clusters of items with similar content (Rodriguez et al., 2016a).
The bi-factor model evaluates the unique contributions of the
general factor and specific factors to scale each individual on a
single trait, but at the same time, controls for the distorting effects
of multi-dimensionality caused by specific item content (Reise
et al., 2010). Thus, to assess whether a bi-factor model could
explain the structure of depressive, anxious and somatic symp-
toms presented by PHC patients, it is important to understand
the specific contribution of each construct of the model on symp-
tom variances (Reise, 2012) (i.e. how reliable and viable each spe-
cific domain is).
Simms et al. (2012) provided a statistical explanation of why
the bi-factor model was expected to be the best fitting latent struc-
ture for similar data when compared with other multi-
dimensional models. This specification of the model is also
aligned with the idea of the P-factor (Caspi et al., 2012; Martel
et al., 2017) to explain the comorbidity across mental disorders,
where a general factor of psychopathology – the P-factor –
accounts for meaningful variance across major forms of hundreds
of psychiatric symptoms.
Based on this rationale, CFA were conducted to evaluate two
bi-factor models of the latent structure of anxiety, depression
and somatic symptoms by using the items of depression and anx-
iety scales as a proxy for depression and anxiety symptoms,
respectively, and the somatic symptoms screening as a proxy for
somatization. Two orthogonal models were tested, where correla-
tions among factors were set to zero: (1) Model 1, where a general
factor was loaded on each symptom along with three depression,
anxiety and somatization specific factors and (2) Model 2, where a
general factor was loaded on each symptom along with two anx-
ious depression and somatization specific factors. The weighted
least squares (WLSMV) estimator was used due to categorical
observed indicators (i.e. set of items) specifying the variable
nation as a cluster indicator dealing with complex structured
data (i.e. participants nested in nations) as suggested by
Asparouhoy (2005, 2006). The evaluation of the model’s fit was
conducted using the following indices: the Chi-Square Test of
Model Fit ( p > 0.05), the Root Mean Square Error of
Approximation (RMSEA < 0.06), the Comparative Fit Index
(CFI > 0.90) and the Tucker–Lewis Index (TLI > 0.90) (Brown,
2015).
Reliability and viability of the general and specific factors
Beyond examining model fit, it is important to evaluate the inter-
pretability of total and subscale scores in a bi-factor model. That
is, whether it is meaningful to report subscale scores in the pres-
ence of multi-dimensionality. This is typically assessed using reli-
ability indices (Rodriguez et al., 2016a). When fitting a bi-factor
model, three sources of symptoms variance might be specified:
(1) those related to the general factor; (2) those related to specific
factors; and (3) those related to error (aka. residual variance). The
purpose of the reliability analysis is to determine whether the
symptoms proposed for depression, anxiety and somatic symp-
toms are reliable indicators of these domains. To evaluate reliabil-
ity, the following indices were considered (Rodriguez et al., 2016a,
2016b): (1) explained common variance (ECV), which is an index
of uni-dimensionality of the model (a ratio of the variance
explained by the general factor divided by the variance explained
by the general and the specific factors); (2) Lucke’s omega, which
indicates the percentage of total score variance (of the three
scales) that can be attributable to all factors modeled and repre-
sents the reliability of the model; (3) the hierarchical omega coef-
ficient, which indicates the degree to which each scale is
interpretable as a measure of a single common factor; and (4)
omega subscales to indicate the reliability of the subscale score
remaining on the specific factor once the effects of the general fac-
tor are removed. Values of the omega indices can vary between 0
and 1, where higher scores indicate greater reliability. Key details
about each index are described in Rodriguez et al. (2016a, 2016b).
External validity
To test the external validity of the specified structural model, we
analyzed the relationship between the latent structure of the mod-
els with ICD-11 PHC diagnoses and disability. The latent factors
(the general measure and the specific factors) were used as
766 Carolina Ziebold et al.
https://doi.org/10.1017/S0033291718001381
Downloaded from https://www.cambridge.org/core. Uniovi, on 02 May 2019 at 10:56:21, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
predictors of AD compared with a depressive episode, current
anxiety, sub-threshold anxious depression and no diagnosis
using ICD-11 PHC criteria. For this analysis, the used estimator
was the Maximum Likelihood generating then a logistic regression
model estimating the subsequent Odds Ratio. Linear regression
was modeled where the outcome variable was disability level
(WHODAS 2.0 total score).
Results
Structural analyses
Both bi-factor specified models (Fig. 1) with all symptoms loading
simultaneously on a general factor, along with one of three
depression, anxiety and somatic specific factors (Model 1) or
two anxious depression and somatic specific factors (Model 2),
fit well to the data. For both models, the inclusion of item 5 of
the depression scale regarding suicidal ideation resulted in
unidentified models in the CFA. As Simms et al. (2012) excluded
this symptom for depression in PHC patients in their model, due
to the low rates of its presentation, we also decided to exclude this
item from our models. Because both models have the same num-
ber of degrees of freedom, they are not comparable one with each
other.
Figure 1 shows the diagrams of both models. Model 1 with
three depression, anxiety and somatic specific factors had the fol-
lowing fit indices: x2 (627) = 741.016, p < 0.0011, RMSEA = 0.015,
(CI90% = 0.010–0.019), CFI = 0.911, TLI = 0.900. Model 2 with
two anxious depression and somatic specific factors had the fol-
lowing fit indices: x2 (627) = 663.065, p = 0.1543, RMSEA =
0.008, (CI90% = 0.000–0.014), CFI = 0.954, TLI = 0.948.
Table 1 presents the prevalence of symptoms and the standar-
dized factor loadings for both the general and specific factors of
Models 1 and 2. Standardized factor loadings represent the degree
to which each item is associated with its underlying factor; values
closer to 1 represent stronger correlations with the underlying fac-
tor. In Model 1, depressive and anxiety specific factor loadings
were higher than those accounted for by the general factor.
Somatic symptoms had similar factor loadings on the general fac-
tor and the somatic specific factor, with the exception of gastro-
intestinal symptoms, where the factor loadings were higher on
the somatic specific factor. The general symptoms (headache, diz-
ziness, memory impairment, concentration difficulties and
fatigue) had higher factor loadings on the general factor than
on the somatic specific factor. In Model 2, when depressive and
anxiety symptoms were considered to correspond to the same
dimension, the specific factor loadings were also higher on the
anxious depression factor but lower on the somatic specific factor.
The screening items of the depression scale had slightly higher
loadings on the general factor compared with anxiety items. In
contrast, somatic symptoms had higher factor loadings on the
general factor (with the exception of ‘diarrhea’) and lower on
the somatic specific factor.
Reliability and subscales viability
Table 1 shows the reliability indices of both models. Even when
Model 2 showed higher ECV, both models could be considered
as measurements of multi-dimensional models. In both models,
Lucke’s omega was 0.95, indicating that all common factors mod-
eled accounted for 95% of the total symptom variance, and only
5% of the variance was due to random error. The hierarchical
omega in Model 2 demonstrates that 67% of the total symptom
variance can be attributed to individual differences in the general
factor. In Model 1, the general factor showed less contribution to
the symptom variances (hierarchical omega = 0.38). Regarding
omega subscales, in Model 1, depression, anxiety and somatic
symptom variances were associated predominantly with specific
depression and anxiety factors after controlling for the general
factor (omega subscale depression = 0.73; omega subscale
anxiety = 0.88) and were moderately associated with the somatic
specific factor (omega subscale = 0.64). This supports the claim
that depression and anxiety scales are reliable indicators of
these dimensional constructs. In Model 2, depression and anxiety
symptom variances were associated predominantly with the spe-
cific anxious depression factor after controlling for the general
factor (omega subscale anxious depression = 0.91). In contrast,
somatic symptom variance had a smaller association with the
somatic specific factor after controlling for the general factor
(omega subscale somatization = 0.20). These results suggest that
the somatic symptom variance is mainly explained by individual
differences in the general factor and had only a residual relation
with a specific dimension of somatization. Thus, considering
these reliability indices, the somatic symptom subscale score
would be considered an ambiguous reflection of that dimension,
justifying the assessment of anxious depression in order to
achieve a more accurate evaluation of a primary care patient
who presents with somatic symptoms not explained by known
physical pathology. In contrast, variation in anxious depression
subscale scores can be attributed mainly to individual differences
in an anxious depression specific dimension.
External validation of the models
Regression analyses were conducted to assess the relationship
between the latent factors (the general measure and the specific
factors) of the models with ICD-11 PHC diagnoses (assessed by
the CIS-R) and disability (WHODAS 2.0 scores). For Model 1,
the general factor strengthened the likelihood of AD diagnosis
as compared with no diagnosis (OR 7.93, CI95% = 1.26–49.82,
p = 0.03) and compared with current anxiety (OR 2.93, CI95% =
0.99–9.70, p = 0.05) but did not increase the likelihood compared
with depression ( p = 0.36) and sub-threshold anxious depression
( p = 0.11). These findings suggest that AD, depression and sub-
threshold anxious depression can be parsimoniously modeled as
a single general syndrome that encompasses depression, anxiety
and somatic symptoms. The levels of the depression specific fac-
tor increased the likelihood of an AD diagnosis compared with
depression (OR 2.65, CI95% = 1.35–5.21, p = 0.01) and current
anxiety (OR 2.83, CI95% = 1.26–6.36, p = 0.01) but remained the
same for sub-threshold anxious depression ( p = 0.34) and no
diagnosis ( p = 0.43). The anxiety specific factor reduced the
odds of having an AD diagnosis compared with current anxiety
diagnosis (OR 0.57, CI95% = 0.38–0.86, p = 0.01). The somatic spe-
cific factor predicted the occurrence of AD compared with no
diagnosis (OR 2.08, CI95% = 1.05–4.13, p = 0.04) and current anx-
iety (OR 1.40, CI95% = 1.11–1.75, p < 0.001). The levels of somatic
factor were similar for depression ( p = 0.61), sub-threshold anx-
ious depression ( p = 0.94) and AD.
For Model 2, the general factor strengthened the likelihood of
AD diagnosis compared with current anxiety (OR 4.98, CI95% =
1.47–16.90, p = 0.01) but did not increase the likelihood compared
with depression ( p = 0.31) and sub-threshold anxious depression
( p = 0.65). For this model, the relationship between diagnosis and
Psychological Medicine 767
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the specific factors was found only for the somatic specific factor,
where higher levels of this factor strengthened the likelihood of
an AD diagnosis compared with no diagnosis (OR 2.09, CI95% =
1.24–3.53, p = 0.006). Regarding disability levels, in Model 1,
WHODAS 2.0 scores were predicted by the general factor (β =
0.34, CI95% = 0.16–0.52, p < 0.001) and by the depression specific
factor (β = 0.27, CI95% = 0.03–0.51, p = 0.025) in a statistically sig-
nificant manner, whereas anxiety and somatization specific factors
failed to correlate with disability (β = 0.06, CI95% =−0.21 to 0.32, p
= 0.669; β = 0.18, CI95% =−0.08 to 0.44, p = 0.178, respectively).
For Model 2, disability levels were predicted by the general factor
(β = 0.38, CI95% = 0.23–0.52, p < 0.001) in a statistically significant
manner, whereas for the specific factors, we found a lack of statis-
tical significance for the anxious depression specific factor (β =
0.18, CI95% =−0.08 to 0.43, p = 0.18) and the somatic specific factor
(β = 0.1, CI95% =−0.11 to 0.30, p = 0.362).
Discussion
We examined the latent structure of depressive, anxiety and som-
atic symptoms presented by PHC patients and its relationship
with ICD-11 PHC diagnoses and disability levels. Two bi-factor
solutions were found with all depressive, anxiety and somatic
symptoms loading simultaneously on a general factor, along
with one of three specific depression, anxiety and somatic factors
or along with one of two specific anxious depression and somatic
factors. The general factor correlated with disability levels and the
new anxious depression diagnosis of the ICD-11 PHC.
In addition, we analyzed the reliability of the symptoms pro-
posed for the ICD-11 PHC to assess psychopathology in PHC
patients. The three scales assessed, encompassing the symptoms
proposed for the depression, anxiety and BSS categories of the
ICD-11 PHC, once the effects of the general factor were removed,
showed different reliability profiles. Depressive and anxiety symp-
toms assessed all together were reliable indicators of a specific
anxious depression dimension. Even when depressive and anxiety
symptoms were evaluated as corresponding to two different
domains (Model 1), they remained reliable indicators of specific
depression and anxiety dimensions, respectively. However, the
somatic symptom screening would be an ambiguous reflection
of a particular construct because the variance of these symptoms
could be attributed mainly to individual differences in the general
factor.
The low omega of the somatization subscale indicates that to
achieve a reliable evaluation of a primary care patient presenting
multiple somatic symptoms it is necessary to apply both assess-
ments: anxious depression and somatic symptoms scales. In
other words, it is not enough to diagnose a patient presenting
multiple somatic symptoms without considering the presence
of depressive and anxious symptoms. This does not suggest
that somatic symptoms are not important, on the contrary,
they are major contributors to disability and severity as was
found in our previous study (Goldberg et al., 2016). Moreover,
it is important to observe that somatic symptoms have moderate
factor loadings onto the general factor, which captures a general
mental health issue. This is also consistent with our findings
regarding the external validity of the models, where the general
factor is a better predictor of disability and mental health
disorders.
Fink et al. (2007) proposed that different patterns of symptoms
described as different ‘functional syndromes’ share a latent under-
lying dimension, and also suggested that there is a high associ-
ation between these various symptoms and emotional disorders.
Simms et al. (2012) studied the latent structure that could explain
this association and found a latent structure similar to the one
found in this investigation, supporting the idea of a broad distress
factor that could explain the presentation of multiple somatic
symptoms and emotional disorders in PHC patients. However,
the current model is different from the Simms et al. model in
two ways. First, we found good fit indices when depressive and
anxiety symptoms were merged into one dimension. This finding
is in line with the wide support to include the category of AD in
the psychopathological nosology, especially in the context of PHC
where the comorbidity of depression and anxiety is the rule rather
than the exception (Gaynes et al., 2007; Lieb et al., 2007; Löwe
et al., 2008; Hanel et al., 2009). Thus, this result provides evidence
that depressive and anxiety symptoms are part of the same latent
construct in PHC patients. Second, compared with depression
and anxiety dimensions assessed by Simms et al. (2012), the
depression, anxiety and anxious depression specific factors in
our model were stronger, e.g. the symptom loadings were higher
on the specific factors compared with the general factor. This
result is rarely found in the field of psychometric analyses of psy-
chopathology measures using bi-factor models (Rodriguez et al.,
2016b). In spite of the multi-dimensionality of the models,
when more items are grouped that share the common latent
Fig. 1. Diagrams representing the bi-factor models structure underlying the depressive, anxiety and somatic symptoms in PHC patients.
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Table 1. Rates, general and specific factors loadings of each symptom and reliability indices of the models.
Model 1 (3 specific factors) Model 2 (2 specific factors)
Symptoms
Rate
%
General
factor
loading
p
value
Specific
factor
loading p value
General
factor
loading
p
value
Specific
factor
loading
p
value
Depressive symptoms
Felt depressed 49.8 0.46 * 0.77 * 0.29 0.003 0.74 *
Less interest or pleasure from activities 57.7 0.36 * 0.86 * 0.23 0.003 0.80 *
Difficulty concentrating 59.8 0.38 * 0.63 * 0.15 0.244 0.74 *
Felt worthless 39.3 0.20 0.013 0.70 * 0.11 0.242 0.66 *
Anxiety symptoms
Nervous or anxious 65.7 0.33 0.002 0.80 * 0.16 0.248 0.83 *
Not able to control worrying 59.0 0.35 * 0.79 * 0.18 0.011 0.83 *
Difficulty relaxing 62.4 0.19 0.063 0.90 * 0.08 0.425 0.89 *
Felt so restless it was hard to keep still 51.1 0.11 0.206 0.85 * 0.03 0.746 0.81 *
Afraid that something awful might happen 46.8 0.01 0.940 0.78 * −0.02 0.854 0.74 *
Somatic symptoms
Abdominal pains 42.7 0.25 0.006 0.48 * 0.50 * 0.22 0.046
Frequent loose bowel movements 19.7 0.14 0.302 0.60 * 0.54 * 0.25 0.080
Feeling bloated 22.2 −0.17 0.062 0.62 * 0.26 0.035 0.53 *
Regurgitations 20.3 −0.01 0.944 0.69 * 0.37 * 0.59 *
Constipation 27.7 0.29 0.001 0.40 * 0.54 * 0.02 0.788
Diarrhea 12.3 −0.28 0.001 0.45 * 0.05 0.395 0.41 *
Nausea 29.2 0.17 0.124 0.70 * 0.39 0.002 0.63 *
Vomiting 15.8 0.06 0.599 0.71 * 0.32 0.044 0.77 *
Burning sensation in epigastrium 22.5 0.03 0.762 0.58 * 0.44 * 0.26 *
Pains in arms or legs 51.4 0.58 * 0.39 * 0.76 * −0.05 0.654
Muscular aches or pains 54.6 0.35 0.006 0.52 * 0.65 * 0.11 0.248
Pains in the joints 37.3 0.36 0.001 0.51 * 0.74 * 0.00 0.994
Feelings of paresis or localized weakness 28.5 0.40 0.002 0.55 * 0.70 * 0.17 0.239
Back ache 47.4 0.38 0.004 0.49 * 0.62 * 0.15 0.059
Pain moving from one place to another 21.1 0.47 * 0.59 * 0.74 * 0.14 0.171
Unpleasant numbness 28.7 0.29 0.003 0.43 * 0.46 * 0.23 0.022
Unpleasant tingling sensations 34.5 0.46 * 0.41 * 0.52 * 0.33 *
Palpitations 52.3 0.42 0.001 0.44 * 0.58 * 0.18 0.126
Precordial discomfort 34.6 0.26 0.008 0.53 * 0.63 * 0.12 0.311
Breathlessness without exertion 30.5 0.25 0.001 0.49 * 0.42 * 0.36 0.001
Hyperventilation 19.9 0.25 0.077 0.60 * 0.52 * 0.39 *
Hot or cold sweats 37.0 0.37 0.006 0.56 * 0.56 * 0.37 *
Trembling or shaking 25.8 0.41 * 0.36 * 0.29 0.001 0.56 *
Dry mouth 42.4 0.58 * 0.52 * 0.56 * 0.49 *
Concentration difficulties 45.3 0.53 * 0.21 0.058 0.51 * 0.03 0.797
Impairment of memory 42.4 0.55 * 0.15 0.179 0.56 * −0.05 0.695
Excessive fatigue 44.5 0.51 * 0.49 * 0.71 * 0.11 0.247
Headache 55.7 0.39 * 0.30 * 0.46 * 0.14 0.018
Dizziness 37.0 0.53 * 0.36 * 0.59 0.001 0.17 0.099
(Continued )
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factor, total scores typically reflect variance due to the broad latent
variable (the general factor). Consequently, subscale scores often
have ambiguous interpretations because their variance mostly
reflects the general rather than the specific trait (Rodriguez
et al., 2016b). Thus, as Simms et al. (2012) found, typically in
bi-factor models of psychopathology, the general factor is robust
compared with the specific traits, and when the reliability indices
are assessed (see Caspi et al., 2014; Rodriguez et al., 2016b; Martel
et al., 2017), they present higher hierarchical omega values and
explained common variance and lower omega subscales com-
pared with those we found.
A possible explanation for this finding is that while Simms
et al. (2012) included in their model all the symptoms of the
Composite International Diagnostic Interview adapted for pri-
mary care (CIDI-PC) related with depression, anxiety and soma-
tization, the depression and anxiety scales assessed here capture
more specific manifestations of these constructs. The two brief
scales (Goldberg et al., 2012) were created using the depression
and anxiety symptoms according to the CIDI-PC, but eliminating
those items produced by systemic physical disease (such as poor
appetite, loss of weight, poor sleep and fatigue). Compared with
the entire scales of the CIDI-PC, there is no overlap between
depressive and anxiety symptoms. Thus, these scales allowed us
to discriminate specific manifestations of depression and anxiety
symptomatology and allowed us to control the effect of neurove-
getative symptoms present in these disorders. In this sense, the
symptoms proposed for depression and anxiety for the ICD-11
PHC are reliable indicators of these categories, and these scales
are useful for PCPs to evaluate patients in PHC settings who pre-
sent with somatic symptoms not explained by known physical
pathology and emotional symptoms.
Nonetheless, somatic symptom variance was mainly explained
by individual differences in the general factor and had only
residual relation with a specific dimension of somatization. This
made sense due to the observed comorbidity between emotional
and functional disorders, as it is known that there may be an over-
lap in the etiology of depression anxiety and somatization (Stein
and Muller, 2008). Nevertheless, a possible explanation for the
lack of reliability of the somatic scale corresponding to a specific
construct independent of the general factor is that the items
assessed did not include specific cognitive patterns presented in
BSS patients. As proposed by Fink et al. (2007), for the ICD-11
PHC, the category of BSS should be restricted to patients who pre-
sent with distress and/or significant disruption in daily life due to
their symptoms and have persistent concerns about the medical
seriousness of their symptoms beyond the somatic symptoms
described (Lam et al., 2013).
This study has several limitations. First, we based our analyses
on a sample of PHC patients from five countries, and future work
is needed to replicate these findings in more diverse PHC settings.
Nevertheless, we found that the structure of depressive, anxious
and somatic symptoms was similar in PHC patients from these
five countries, providing evidence that the structure of these
symptoms is inherent rather than a manifestation of location-
specific patterns. Second, the recruitment of participants was
based on judgment from the PCPs that the patients exhibited
somatic symptoms not explained by known physical pathology
without further medical evaluation. However, this actually can
be seen as enhancing the external validity of this study, replicating
the problems faced by PCPs in their routine practice. Third, the
selection of patients presenting multiple somatic symptoms not
explained by known physical pathology could incline PCPs to
select patients who fit into their own ideas about patients present-
ing this symptoms profile, besides their somatic symptoms, also
must have some mental disorders. In this sense, it is advisable
to replicate this study with a cross-sectional sample of all consecu-
tive patients attending primary care.
Despite these limitations, this study provides evidence to better
understand the clinical presentation of mental health problems in
PHC and to integrate in the ICD-11 PHC a dimensional approach
to sensitize primary care workers to recognize the manifestations
of multiple somatic symptoms not explained by known physical
pathology as an expression of an underlying latent phenomenon
which would explain the common occurrence of depression, anx-
iety and somatization. This dimensional approach could contrib-
ute to the recognition of mental health problems, which is a first
step towards the reduction of the treatment gap (Shidhaye et al.,
2013). Consistent with previous studies, these findings suggest
that depression, anxiety and somatization are different presenta-
tions of a common latent phenomenon. Thus, this study provides
support for the ICD-11 PHC conceptualization of mood disturb-
ance, especially AD, as central among patients who present mul-
tiple somatic symptoms.
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Üstün TB and Sartorius N (1995) Mental Illness in General Health Care: An
International Study. Chichester: Wiley.
World Health Organization (1992) The ICD-10 Classification of Mental and
Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines.
Geneva: Author.
World Health Organization (2010)Measuring Health and Disability: Manual
for WHO Disability Assessment Schedule WHODAS 2.0. Geneva: World
Health Organization.
Psychological Medicine 771
https://doi.org/10.1017/S0033291718001381
Downloaded from https://www.cambridge.org/core. Uniovi, on 02 May 2019 at 10:56:21, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
